Feb 07, 2024 / 08:00AM GMT
Presentation
Feb 07, 2024 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Antoinette L. Gawin
Terumo Corporation - Group Managing Executive Officer and President of Blood & Cell Technologies Company
* Naoki Muto
Terumo Corporation - Chief Accounting & Financial Officer and Group Executive Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Mizuho Securities Co., Ltd., Research Division - Senior Analyst
* Ryotaro Hayashi
Morgan Stanley, Research Division - Equity Analyst
* Shinnosuke Tokumoto
SMBC Nikko Securities Inc., Research Division - Analyst
* Stephen Barker
Jefferies LLC, Research Division - Equity Analyst
* Takahiro Mori
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Takashi Akahane
Tokai Tokyo Research Institute Co., Ltd. - Senior Analyst
* Tomoko
Terumo Corp
(TSE:4543)
円
2,288
-35 (-1.51%)
Market Cap: 3.37 Tn
Enterprise Value: 3.47 Tn
PE Ratio: 24.84
PB Ratio: 2.14
GF Score: 89/100 Q3 2024 Terumo Corp Earnings Presentation Transcript
Feb 07, 2024 / 08:00AM GMT
Release Date Price:
円2536.5
(+1.48%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot